LON:TSTLTristel Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Tristel Plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 410 +9.00 (+2.24 %) (As of 07/10/2020 04:00 PM ET) Add Compare Share Today's Range 395.20Now: GBX 410▼ 41550-Day Range 400MA: GBX 459.03▼ 52052-Week Range 260Now: GBX 410▼ 534Volume57,476 shsAverage Volume35,859 shsMarket Capitalization£185.72 millionP/E Ratio40.59Dividend Yield1.44%BetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsInsider TradesHeadlines Tristel Plc develops, manufactures, and supplies infection and contamination control, and hygiene products in the United Kingdom, Germany, and internationally. The company operates through three segments: Human Healthcare, Animal Healthcare, and Contamination Control. It offers hospital infection prevention and control products under the Tristel brand; contamination control products for pharmaceutical and personal care industries under the Crystel brand; and animal health infection prevention and control products under the Anistel brand. Tristel Plc was founded in 1993 and is based in Snailwell, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Tristel. Previous Next 2.0 Community Rank Outperform VotesTristel has received 146 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTristel has received 220 “underperform” votes. (Add your “underperform” vote.)Community SentimentTristel has received 60.11% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Tristel and other stocks. Vote “Outperform” if you believe TSTL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TSTL will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.8 Dividend Strength Dividend YieldTristel has a dividend yield of 1.44%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthTristel does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Tristel is 59.41%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Tristel insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Tristel are expected to decrease by -100.00% in the coming year, from GBX 1,171.08 to GBX 0 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tristel is 40.59, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.33.Price to Earnings Ratio vs. SectorThe P/E ratio of Tristel is 40.59, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.32.Price to Book Value per Share RatioTristel has a P/B Ratio of 7.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.57 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolLON:TSTL Previous Symbol CUSIPN/A CIKN/A Webwww.tristel.com Phone+44-1638-721500Debt Debt-to-Equity Ratio16.09 Current Ratio3.15 Quick Ratio2.43Price-To-Earnings Trailing P/E Ratio40.59 Forward P/E Ratio0.35 P/E GrowthN/A Sales & Book Value Annual Sales£28.79 million Price / Sales6.45 Cash FlowGBX 9.41 per share Price / Cash Flow43.55 Book ValueGBX 54.30 per share Price / Book7.55Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees121 Outstanding Shares45,296,500Market Cap£185.72 million Next Earnings DateN/A OptionableNot Optionable LSE:TSTL Rates by TradingView Receive TSTL News and Ratings via Email Sign-up to receive the latest news and ratings for TSTL and its competitors with MarketBeat's FREE daily newsletter. Tristel (LON:TSTL) Frequently Asked Questions How has Tristel's stock been impacted by COVID-19 (Coronavirus)? Tristel's stock was trading at GBX 455 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TSTL shares have decreased by 9.9% and is now trading at GBX 410. View which stocks have been most impacted by Coronavirus. How were Tristel's earnings last quarter? Tristel Plc (LON:TSTL) issued its quarterly earnings data on Monday, February, 24th. The company reported $5.37 EPS for the quarter. View Tristel's earnings history. How often does Tristel pay dividends? What is the dividend yield for Tristel? Tristel announced a dividend on Monday, February 24th. Stockholders of record on Thursday, March 26th will be paid a dividend of GBX 2.34 per share on Thursday, April 30th. This represents a dividend yield of 0.53%. The ex-dividend date is Thursday, March 26th. The official announcement can be viewed at this link. View Tristel's dividend history. Has Tristel been receiving favorable news coverage? Headlines about TSTL stock have trended neutral recently, InfoTrie reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Tristel earned a coverage optimism score of 0.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Tristel. Who are some of Tristel's key competitors? Some companies that are related to Tristel include Advanced Medical Solutions Group (AMS), Clover (CLV), InfuSystem (INFU), Bovie Medical (BVX), CRH Medical (CRH), Retractable Technologies (RVP), CRH Medical (CRHM), CRH Medical (CRHM), SDI (SDI), Milestone Scientific (MLSS), Omega Diagnostics Group (ODX), Daxor (DXR), Daxor (DXR), IsoRay (ISR) and IsoRay (ISR). View all competitors. What other stocks do shareholders of Tristel own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tristel investors own include Standard Life Aberdeen (SL), Barclays (BARC), BP (BP), Capital One Financial (COF), De La Rue (DLAR), Man Group (EMG), McCarthy & Stone (MCS), Mediclinic International (MDC), Meggitt (MEGGF) and Sprott Physical Gold Trust (PHYS). Who are Tristel's key executives? Tristel's management team includes the following people: Mr. Paul C. Swinney, CEO & Exec. Director (Age 60)Ms. Elizabeth A. Dixon, Fin. Director, Company Sec. & Exec. Director (Age 49)Mr. Bart Victor Margaretha Leemans, Exec. Director (Age 56) What is Tristel's stock symbol? Tristel trades on the London Stock Exchange (LON) under the ticker symbol "TSTL." How do I buy shares of Tristel? Shares of TSTL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Tristel's stock price today? One share of TSTL stock can currently be purchased for approximately GBX 410. How big of a company is Tristel? Tristel has a market capitalization of £185.72 million and generates £28.79 million in revenue each year. Tristel employs 121 workers across the globe. What is Tristel's official website? The official website for Tristel is www.tristel.com. How can I contact Tristel? Tristel's mailing address is Lynx Business Park,Fordham Road, SNAILWELL, CB8 7NY, United Kingdom. The company can be reached via phone at +44-1638-721500. This page was last updated on 7/11/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
